Published online Aug 21, 2017. doi: 10.3748/wjg.v23.i31.5798
Peer-review started: February 9, 2017
First decision: May 12, 2017
Revised: June 18, 2017
Accepted: July 12, 2017
Article in press: July 12, 2017
Published online: August 21, 2017
Processing time: 192 Days and 13.2 Hours
To assess the efficacy of a modified approach with transanal total mesorectal excision (taTME) using simple customized instruments in male patients with low rectal cancer.
A total of 115 male patients with low rectal cancer from December 2006 to August 2015 were retrospectively studied. All patients had a bulky tumor (tumor diameter ≥ 40 mm). Forty-one patients (group A) underwent a classical approach of transabdominal total mesorectal excision (TME) and transanal intersphincteric resection (ISR), and the other 74 patients (group B) underwent a modified approach with transabdominal TME, transanal ISR, and taTME. Some simple instruments including modified retractors and an anal dilator with a papilionaceous fixture were used to perform taTME. The operative time, quality of mesorectal excision, circumferential resection margin, local recurrence, and postoperative survival were evaluated.
All 115 patients had successful sphincter preservation. The operative time in group B (240 min, range: 160-330 min) was significantly shorter than that in group A (280 min, range: 200-360 min; P = 0.000). Compared with group A, more complete distal mesorectum and total mesorectum were achieved in group B (100% vs 75.6%, P = 0.000; 90.5% vs 70.7%, P = 0.008, respectively). After 46.1 ± 25.6 mo follow-up, group B had a lower local recurrence rate and higher disease-free survival rate compared with group A, but these differences were not statistically significant (5.4% vs 14.6%, P = 0.093; 79.5% vs 65.1%, P = 0.130).
Retrograde taTME with simple customized instruments can achieve high-quality TME, and it might be an effective and economical alternative for male patients with bulky tumors.
Core tip: Distal mesorectal excision is difficult in male patients with low rectal cancers, especially with a bulky tumor. We explored the application of simple instruments including modified retractors and an anal dilator with a papilionaceous fixture to perform transanal total mesorectal excision (taTME) in male patients with low rectal cancer. Our results showed that the modified approach with taTME achieved a shorter operative time and better quality of mesorectal excision as compared with the classical approach. This procedure may be an effective and economical alternative for taTME when a giant tumor is encountered in patients with low rectal cancer.